Carpenter, Andrea JeanSchool of Medicine |
|
| 11/2013 - Present | Residency Program Director, Thoracic Surgery and Residency Director | University of Texas Health Science Center San Antonio, Cardiothoracic Surgery, San Antonio, TX |
| 9/2009 - Present | Professor/Clinical | University of Texas Health Science Center San Antonio, Medicine, San Antonio, TX |
| 9/2005 - Present | Active Staff | Cancer Therapy and Research Center, Surgery, San Antonio, TX |
| 1/2003 - Present | Active Staff | Baptist Health System, Surgery, San Antonio, TX |
| 10/2002 - Present | Active Staff | Christus Santa Rosa Medical Center, Surgery, San Antonio, TX |
| 8/2002 - Present | Provider | University of Texas Medicine, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1997 | Residency | Thoracic Surgery | University of California Davis Medical Center Sacramento , CA |
| 1995 | Clinical Fellowship | Thoracic Surgery Research | University of California Davis Medical Center Sacramento , CA |
| 1994 | Residency | General Surgery | David Grant USAF Medical Center Travis AFB , CA |
| 1989 | MD | Medicine | George Washington University Washington , DC |
| 1981 | PhD | Physiology | The Pennsylvania State University State College , PA |
| 1977 | MS | Physical Education | University of Utah Salt Lake City , UT |
| 1974 | BS | Physical Education | Appalachian State University Boone , NC |
Adult Cardiac Surgery- Provide patient care and resident education for a full array of adult cardiac surgery with particular expertise in management of the aortic root with a large series of aortic root and arch reconstruction for aneurysmal disease and dissection. Active participant in the implementation of evolving technologies in our group including trans-catheter valve replacement and endovascualar thoracic aortic repair |
General Thoracic Surgery- Very active with clinical evaluation and operative therapy for lung cancer, teaching thoracic and general surgery residents preoperative evaluation, operative technique and postoperative management until our Department separated the Adult Cardiac and Thoracic into separate Divisions. |
Lung and Heart Transplantation- UNOS certified surgeon actively involved in the lung and heart transplant programs from 2002 until 2012. From 2002 - 2007 the primary surgeon to provide preoperative evaluation of lung transplant candidates including review of history and all studies, examination and extensive preoperative counseling. Committed to the success of the lung transplant program as an operating surgeon while evolving greater expertise in heart failure management working to promote the growth of the heart transplant program. With transition of our department into separate adult cardiac and thoracic teams in 2012 my direct involvement with the lung program has been limited to procurement support. |
Resident Education- Committed to developing the best possible curricula for training the next generation of Thoracic Surgeons. I was the Associate Program Director of our Integrated Thoracic residency from 2013 - 2104 and now Program Director since 2014. Very active in national curriculum development working with the Joint Council on Thoracic Surgery Education as a curriculum editor, member of the simulation development committee and member of the resident assessment committee. |
| Date | Description | Institution | # Students |
| 7/2009 - Present | Post Graduate Rotation Supervision | UTHSCSA | |
Abstract |
| Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, DeMarco VG. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury: Springer; 2018 Jul. (Cardiovascular Diabetology; vol. 17, no. 1). |
Book Chapter |
| Stasik CN, Carpenter AJ. Repair of Traumatic Aortic Injury. In: Grover FL, Mack M (eds.). Master Techniques in Adult Cardiac Surgery. Philadelphia: Wolters Kluwer; 2016. p. 271-282. |
| Carpenter AJ, Y.J. Woo. Simulation and Education in Cardiac Surgery. In: W. Randolph Chitwood, Jr. Atlas of Robotic Cardiac Surgery. New York: Springer-Verlag; 2014. p. 313-319. |
Editorial |
| Carpenter AJ. Simulation is a valuable tool for team training J. Thorac Cardiovasc Surg 2018 Jun;155(6). |
| Carpenter AJ. Invited Commentary: Pericardiectomy for Constrictive Pericarditis: 20 years of Experience at the Montreal Heart Institute Ann Thorac Surg 2015 Jul;100(1):113-113. |
| Carpenter AJ. Invited Commentary: Two internal thoracic arteries really are better J Thorac Cardiovasc Surg 2014 Oct;148(4):1266-1266. |
Journal Article |
| Blackmon SH and Carpenter AJ. Nina Starr Braunwald`s Career,Legacy and Awards: Results of a Survey of the Thoracic Surgery Foundation Award Recipients Ann Thorac Surg 2018 Aug;106(2):633-636. |
| Das NA, Carpenter AJ, Yoshida T, Kumar SA, Gautam S, Mostany R., Isadpanah R, Kumar A, Mummidi S, Siebenlist U, Chandrasekar B. TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart Journal of Molecular and Cellular Cardiology 2018 Aug;121:107-123. |
| Padilla, Jaume, Carpenter AJ, Das NA, Kandikattu, Hemanth, Lopez-Ongil, Susana, Martinez-Lemus, Luis A, Siebenlist, Ulrich, DeMarco, Vincent G, Chandrasekar, Bysani. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells American Journal of Physiology. Heart and Circulatory Physiology 2018 Jan;314(1):52-64. |
| Mummidi S., Das NA, Carpenter AJ, Kandikattu H, Krenz M, Siebenlist U, Valente AJ, Chandrasekar B. Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone salt-induced cardiac fibrosis in vivo Journal of Molecular and Cellular Cardiology 2017 Sep;98:95-102. |
| Carpenter AJ. Gamification in thoracic surgical education: Using competition to fuel performance J Thorac Cardiovasc Surg 2015 Jul;. |
Private |
|
| Funding Agency | Edwards Lifesciences LLC |
| Title | The Safety and Effectiveness of the SAPIEN XTTM Transcather Heart Valve with NovaFlex and Ascendra delivery systems in Intermediate and High Risk for Aortic Valve Surgery and Patients Who Cannot Undergo Surgery and the SAPIEN 3TM Transcather Heart Valve |
| Status | Active |
| Period | 7/2012 - 7/2020 |
| Role | Co-Investigator |
| Grant Detail | |